A Study of TMC435 in Combination With Pegylated Interferon Alp\Fa-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Clinical trial NCT00882908 · COMPLETED
Trial details
- NCT number
- NCT00882908
- Sponsor
- Tibotec Pharmaceuticals, Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-04-01
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.